The UK Competition Authority fines four pharmaceutical companies a total of £3,4 million for breaching competition law in relation to the supply of the antidepressant drug for market sharing and exchanging sensitive information (King Pharmaceuticals / Auden Mckenzie / Lexon / Alissa Healthcare)

Richard Burton

The UK Competition Authority fines four pharmaceutical companies a total of £3,4 million for breaching competition law in relation to the supply of the antidepressant drug for market sharing and exchanging sensitive information (King Pharmaceuticals / Auden Mckenzie / Lexon / Alissa Healthcare)

2020

Richard Burton

On 4 March 2020, the UK's Competition and Markets Authority (“CMA”) fined four pharmaceutical companies a total of £ 3.4 million for breaching competition law in relation to the supply of the…

Keywords:

Cartel
Finance
Exchange of information
Competition law
Price fixing
Business
Health care
Information sensitivity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations